Chen M, Huang Y, Jiang S, Ke C, et al. Safety assessment of KRAS (G12C) inhibitors based on the FDA Adverse Event Reporting System (FAERS) database: A real-world pharmacovigilance study. Lung Cancer 2024;196:107966.
PMID: 39342769